Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
批准号:
478259
负责人:
Dhingra Sanjiv
金额:
$74.87万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2028-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Stem cells-based therapies are considered a novel option for the treatment of different disease conditions including heart disease. Stem cells have the ability to repair the heart after an injury due to heart attack. Bone marrow derived mesenchymal stem c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:444561
-
项目类别:Operating Grants
-
资助金额:$69.94万
-
财政年份:2021
-
负责人:Dhingra Sanjiv
-
依托单位:
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
-
批准号:370541
-
项目类别:Operating Grants
-
资助金额:$54.62万
-
财政年份:2017
-
负责人:Dhingra Sanjiv
-
依托单位:
Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart
-
批准号:321665
-
项目类别:Operating Grants
-
资助金额:$37.97万
-
财政年份:2015
-
负责人:Dhingra Sanjiv
-
依托单位:
海外基金